Company intelligence / Profile preview

Cellutions

Bielefeld, North Rhine-Westphalia, Germany

Ownership: Private
Development stage: Other

Overview

Cellutions is a German life sciences company specializing in the development and production of high-performance cell culture media and supplements for the biopharmaceutical industry. Founded in 2021 and based in Bielefeld, the company focuses on providing chemically defined, animal-derived component-free (ADCF) media tailored for mammalian cell lines such as CHO and HEK. Cellutions offers a range of off-the-shelf media products under the CelluS brand, as well as customized media development and process optimization services. Their solutions are designed to enhance productivity and scalability in the manufacturing of monoclonal antibodies, recombinant proteins, and viral vectors for therapeutic use.

Modalities: Monoclonal antibodyRecombinant proteinViral vector
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Cellutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellutions.

Explore the full profile